0% and 169%, respectively)

There were also some discrep

0% and 16.9%, respectively).

There were also some discrepancies concerning the region of origin: in the cohort, German origin was more common (76.3% and 68.7%, respectively), while patients originating from sub-Saharan Africa and South and South-East Asia were particularly underrepresented. However, a good general correlation with national surveillance data (and hence representativeness at the national level) is the main strength of the ClinSurv HIV cohort compared with another HIV-infected cohort implemented in Germany in 2004, the patient cohort of the German Competence Network Selleck NU7441 for HIV/AIDS (KompNet) [24]. Although KompNet started data collection at 44 sites, because of reduced financing this number had to be reduced and is currently 25 sites. As patient enrolment in KompNet requires informed consent, comparison of the composition of this cohort with the composition of the national German HIV surveillance database reveals significant differences with regard to sex, age and transmission

group category [24]. However, the KompNet cohort collects more variables than ClinSurv HIV. The number of patients enrolled in KompNet HIV decreased from a total of 6817 new annual cases in 2005 to 1147 cases in 2007, while patient enrolment in ClinSurv HIV turned out to be very stable in the long term (Fig. 2). In Germany, Ceritinib clinical trial a growing proportion of HIV-infected patients, especially at early stages of HIV infection, are treated by primary care physicians, who have special training in HIV treatment. They co-operate with the participating clinical

centres if their patients reach advanced disease stages. As the ClinSurv sites are very experienced in HIV treatment, the proportion of patients with advanced clinical stage disease or AIDS may be overrepresented in the cohort, explaining why the cohort is estimated to represent nearly one-third of all patients in HIV stage CDC-C, but only 20% of all PLWHA. In addition to the limited number of variables collected in ClinSurv HIV, another limitation of this cohort study is PTK6 the unequal geographical distribution of sites, which are situated predominantly in the north, north-east and west of the country. However, the study population is surprisingly stable with regard to newly enrolled patients and loss to follow-up, in particular taking into consideration the open observational cohort design. Another advantage is that patients’ informed consent is not needed as the data collection remains under federal law regulations. This makes data collection more representative than in studies requiring informed consent, although the number of variables is more limited. The proportion of ∼11% of patients lost to follow-up seems rather high; however, this number reflects the German situation, where patients, including PLWHA, are free to choose their treating physician when they seek for medical care.

Leave a Reply

Your email address will not be published. Required fields are marked *


You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>